| Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms EM El-Omar, CS Rabkin, MD Gammon, TL Vaughan, HA Risch, ... Gastroenterology 124 (5), 1193-1201, 2003 | 1185 | 2003 |
| Population attributable risks of esophageal and gastric cancers LS Engel, WH Chow, TL Vaughan, MD Gammon, HA Risch, JL Stanford, ... Journal of the National Cancer Institute 95 (18), 1404-1413, 2003 | 921 | 2003 |
| Bone sarcomas linked to radiotherapy and chemotherapy in children MA Tucker, GJ D'Angio, JD Boice Jr, LC Strong, FP Li, M Stovall, BJ Stone, ... New England Journal of Medicine 317 (10), 588-593, 1987 | 897 | 1987 |
| Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia WH Chow, WJ Blot, TL Vaughan, HA Risch, MD Gammon, JL Stanford, ... JNCI: Journal of the National Cancer Institute 90 (2), 150-155, 1998 | 788 | 1998 |
| Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia MD Gammon, H Ahsan, JB Schoenberg, AB West, H Rotterdam, S Niwa, ... Journal of the National Cancer Institute 89 (17), 1277-1284, 1997 | 776 | 1997 |
| An Inverse Relation between cagA+ Strains of Helicobacter pylori Infection and Risk of Esophageal and Gastric Cardia Adenocarcinoma WH Chow, MJ Blaser, WJ Blot, MD Gammon, TL Vaughan, HA Risch, ... Cancer research 58 (4), 588-590, 1998 | 718 | 1998 |
| Epidemiology and pathogenesis of esophageal cancer RS Holmes, TL Vaughan Seminars in radiation oncology 17 (1), 2-9, 2007 | 717 | 2007 |
| Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. TL Vaughan, S Davis, A Kristal, DB Thomas Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1995 | 690 | 1995 |
| Nutrient intake and risk of subtypes of esophageal and gastric cancer ST Mayne, HA Risch, R Dubrow, WH Chow, MD Gammon, TL Vaughan, ... Cancer Epidemiology Biomarkers & Prevention 10 (10), 1055-1062, 2001 | 625 | 2001 |
| Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. DC Farrow, TL Vaughan, PD Hansten, JL Stanford, HA Risch, ... Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1998 | 584 | 1998 |
| Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis BJ Reid, X Li, PC Galipeau, TL Vaughan Nature reviews Cancer 10 (2), 87-101, 2010 | 461 | 2010 |
| Occupational exposure assessment in case–control studies: opportunities for improvement K Teschke, AF Olshan, JL Daniels, AJ De Roos, CG Parks, M Schulz, ... Occupational and environmental medicine 59 (9), 575-594, 2002 | 454 | 2002 |
| Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium MB Cook, F Kamangar, DC Whiteman, ND Freedman, MD Gammon, ... Journal of the National Cancer Institute 102 (17), 1344-1353, 2010 | 379 | 2010 |
| Central adiposity and risk of Barrett’s esophagus ZR Edelstein, DC Farrow, MP Bronner, SN Rosen, TL Vaughan Gastroenterology 133 (2), 403-411, 2007 | 378 | 2007 |
| Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium C Hoyo, MB Cook, F Kamangar, ND Freedman, DC Whiteman, ... International journal of epidemiology 41 (6), 1706-1718, 2012 | 367 | 2012 |
| Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease MF Buas, TL Vaughan Seminars in radiation oncology 23 (1), 3-9, 2013 | 350 | 2013 |
| Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus RE Rudolph, TL Vaughan, BE Storer, RC Haggitt, PS Rabinovitch, ... Annals of Internal Medicine 132 (8), 612-620, 2000 | 343 | 2000 |
| A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors GL Hold, CS Rabkin, WH Chow, MG Smith, MD Gammon, HA Risch, ... Gastroenterology 132 (3), 905-912, 2007 | 329 | 2007 |
| Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer DC Farrow, TL Vaughan, C Sweeney, MD Gammon, WH Chow, HA Risch, ... Cancer Causes & Control 11, 231-238, 2000 | 316 | 2000 |
| NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma PC Galipeau, X Li, PL Blount, CC Maley, CA Sanchez, RD Odze, K Ayub, ... PLoS medicine 4 (2), e67, 2007 | 289 | 2007 |
